Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide vs Alendronate vs Zoledronic acid for secondary osteoporosis
IRCT201605159014N98Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of teriparatide, alendronate and zoledronic acid in secondary osteoporosis (3 arms), sponsored by Hamadan University of Medical Sciences. Started May 2016; status: completed.
02
Drugs
teriparatidealendronatezoledronic acid
03
Conditions
secondary osteoporosis
Beyond the preview
Go deeper on IRCT201605159014N98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201605159014N98.